Skip to main content
Erschienen in: High Blood Pressure & Cardiovascular Prevention 4/2014

01.12.2014 | Original Article

A Randomized Controlled Trial of the Effects of Aerobic Dance Training on Blood Lipids Among Individuals with Hypertension on a Thiazide

verfasst von: Fatai A. Maruf, Aderonke O. Akinpelu, Babatunde L. Salako

Erschienen in: High Blood Pressure & Cardiovascular Prevention | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypertension is associated with dyslipidemia. Thiazides adversely affect serum lipid levels in hypertensives. There is currently a dearth of information on benefits of aerobic exercise training on serum lipid levels in individuals on thiazides and this study aimed at bridging this gap in knowledge.

Methods

This randomized-controlled trial involved 120 newly-diagnosed adults with essential hypertension (≥65 years). They were treated with 50 mg of hydrochlorothiazide + 5 mg of hydrochloride amiloride and 5 or 10 mg of amlodipine for 4–6 weeks before they were randomly assigned into exercise group (EG) and control croup (CG). Only EG underwent 12-week aerobic dance training at 50–70 % of heart rate reserve three times per week. Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, triglyceride and total cholesterol were measured and recorded at baseline and post-study.

Results

Eighty-eight (45 in EG and 43 in CG) of 120 participants randomly assigned to groups completed the study. Systolic (p = 0.370) and diastolic (p = 0.771) blood pressures (BP) were similar between the two groups at baseline. Systolic (p < 0.001) and diastolic (p < 0.001) BPs reduced significantly in exercise and control groups. LDL-C (from 120.10 ± 33.41 to 110.50 ± 31.68 mg/dl; p = 0.037) and triglyceride (from 117.49 ± 45.12 to 100.63 ± 35.42 mg/dl; p = 0.002) decreased in EG post-study but no significant between-group differences were observed.

Conclusions

Although, LDL-C and triglyceride are reduced after aerobic dance training, they were not any more than without it. Aerobic dance training has favorable effects on LDL-C, triglyceride, and systolic and diastolic BP in individuals with hypertension on a thiazide.
Literatur
1.
Zurück zum Zitat Abdul-Khader AA. Lipid profile and antihypertensive drugs. Al-Kindy Coll Med J. 2009;5(1):1–4. Abdul-Khader AA. Lipid profile and antihypertensive drugs. Al-Kindy Coll Med J. 2009;5(1):1–4.
4.
Zurück zum Zitat Black HR. Metabolic consideration in the choice of therapy for the patient with hypertension. Am Heart J. 1991;121:707–15.PubMedCrossRef Black HR. Metabolic consideration in the choice of therapy for the patient with hypertension. Am Heart J. 1991;121:707–15.PubMedCrossRef
5.
Zurück zum Zitat Krone W, Naggele H. Effects of antihypertensives on plasma lipids and lipoprotein metabolism. Am Heart J. 1988;116:1729–34.PubMedCrossRef Krone W, Naggele H. Effects of antihypertensives on plasma lipids and lipoprotein metabolism. Am Heart J. 1988;116:1729–34.PubMedCrossRef
6.
Zurück zum Zitat Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. Effects of propranolol and prazosin on blood lipids. Lancet. 1980;2(8184):4–6.PubMedCrossRef Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. Effects of propranolol and prazosin on blood lipids. Lancet. 1980;2(8184):4–6.PubMedCrossRef
7.
Zurück zum Zitat Kannel WB, Carter BL. Initial drug therapy for hypertensive patients with hyperlipidemia. Am Heart J. 1989;118:1012–21.PubMedCrossRef Kannel WB, Carter BL. Initial drug therapy for hypertensive patients with hyperlipidemia. Am Heart J. 1989;118:1012–21.PubMedCrossRef
8.
Zurück zum Zitat Iyalomhe GBS, Omogbai EKI, Iyahlome OOB. Effects of amlodipine and hydrochlorothiazide combination therapy on lipid profiles in hypertensive Nigerians. Am J Pharm Sci. 2013;1(2):22–8.CrossRef Iyalomhe GBS, Omogbai EKI, Iyahlome OOB. Effects of amlodipine and hydrochlorothiazide combination therapy on lipid profiles in hypertensive Nigerians. Am J Pharm Sci. 2013;1(2):22–8.CrossRef
9.
Zurück zum Zitat Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and β blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Arch Intern Med. 1999;159:551–8.PubMedCrossRef Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and β blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Arch Intern Med. 1999;159:551–8.PubMedCrossRef
10.
Zurück zum Zitat Pool PE, Sergean SC, Salel AF. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol. 1985;56:86H–91H.PubMedCrossRef Pool PE, Sergean SC, Salel AF. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol. 1985;56:86H–91H.PubMedCrossRef
11.
Zurück zum Zitat Bangalore S, Parkar S, Grossman E, Messerli FA. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol. 2007;100:1254–62.PubMedCrossRef Bangalore S, Parkar S, Grossman E, Messerli FA. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol. 2007;100:1254–62.PubMedCrossRef
12.
Zurück zum Zitat Alderman MH. New onset of diabetes during hypertensive therapy. Am J Hpertens. 2008;21:493–9.CrossRef Alderman MH. New onset of diabetes during hypertensive therapy. Am J Hpertens. 2008;21:493–9.CrossRef
13.
Zurück zum Zitat Tocci G, Panemi F, Palano F, Sciarretta S, Ferrucci A, Kurtz T, Mancia G, Volpe M. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: meta-analysis of placebo-controlled clinical trials. Am J Hypertens. 2011;24:582–90.PubMedCrossRef Tocci G, Panemi F, Palano F, Sciarretta S, Ferrucci A, Kurtz T, Mancia G, Volpe M. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: meta-analysis of placebo-controlled clinical trials. Am J Hypertens. 2011;24:582–90.PubMedCrossRef
15.
Zurück zum Zitat Mancia G, Fagard R, Narkiewics K, Redon J, Zauchetti A, Bohm M, et al. ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension (ESH) and of European Journal of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.PubMedCrossRef Mancia G, Fagard R, Narkiewics K, Redon J, Zauchetti A, Bohm M, et al. ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension (ESH) and of European Journal of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.PubMedCrossRef
16.
Zurück zum Zitat Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15:247–57.PubMedCrossRef Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15:247–57.PubMedCrossRef
17.
Zurück zum Zitat Physical Activity Guidelines Advisory Committee Report, Washington: US Department of Health and Human Services; 2008. Physical Activity Guidelines Advisory Committee Report, Washington: US Department of Health and Human Services; 2008.
18.
Zurück zum Zitat Ketelhut RG, Franz IW, Scholze J. Regular exercise as an effective approach in antihypertensive therapy. Med Sci Sports Exerc. 2004;36:4–8.PubMedCrossRef Ketelhut RG, Franz IW, Scholze J. Regular exercise as an effective approach in antihypertensive therapy. Med Sci Sports Exerc. 2004;36:4–8.PubMedCrossRef
19.
Zurück zum Zitat Laterza MC, de Matos LDN, Trombetta IC, et al. Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension. 2007;49:1298.PubMedCrossRef Laterza MC, de Matos LDN, Trombetta IC, et al. Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension. 2007;49:1298.PubMedCrossRef
20.
Zurück zum Zitat Burke V, Beilin LJ, Cutt HE, Mansour J, Williams A, Mori TA. A lifestyle programme for treated-hypertensives-improved-health-related behaviours and cardiovascular risk factors, a randomized control trial. J Clin Epidemiol. 2007;60:133–41.PubMedCrossRef Burke V, Beilin LJ, Cutt HE, Mansour J, Williams A, Mori TA. A lifestyle programme for treated-hypertensives-improved-health-related behaviours and cardiovascular risk factors, a randomized control trial. J Clin Epidemiol. 2007;60:133–41.PubMedCrossRef
21.
Zurück zum Zitat Xue F, Yao W, Lewin RJ. A randomised trial of a 5-week, manual-based, self-management programme for hypertension delivered in a cardiac patient club in Shanghai. BMC Cardiovasc Disord. 2008;8:10.PubMedCentralPubMedCrossRef Xue F, Yao W, Lewin RJ. A randomised trial of a 5-week, manual-based, self-management programme for hypertension delivered in a cardiac patient club in Shanghai. BMC Cardiovasc Disord. 2008;8:10.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy: effects on lipids, blood pressure, and left ventricular mass. J Am Med Assoc. 1990;263(20):2766–71.CrossRef Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy: effects on lipids, blood pressure, and left ventricular mass. J Am Med Assoc. 1990;263(20):2766–71.CrossRef
23.
Zurück zum Zitat Kahrs SJ, Weinstein C, Douwes J, Alexander MD, Weinstein S. Effect of exercise training and diet modification on serum lipids and lipoproteins in coronary artery disease patients treated with thiazides. Clin Cardiol. 1985;8:636–40.PubMedCrossRef Kahrs SJ, Weinstein C, Douwes J, Alexander MD, Weinstein S. Effect of exercise training and diet modification on serum lipids and lipoproteins in coronary artery disease patients treated with thiazides. Clin Cardiol. 1985;8:636–40.PubMedCrossRef
24.
Zurück zum Zitat Maruf FA, Akinpelu AO, Salako BL. Self-reported quality of life before and after aerobic exercise training in individuals with hypertension: a randomized-controlled trial. Appl Psychol Health Well Being. 2013;5(2):209–24.PubMedCrossRef Maruf FA, Akinpelu AO, Salako BL. Self-reported quality of life before and after aerobic exercise training in individuals with hypertension: a randomized-controlled trial. Appl Psychol Health Well Being. 2013;5(2):209–24.PubMedCrossRef
25.
Zurück zum Zitat Wilson DK, Kliewer W, Pylobon L, Sica D. Socioeconomic status and blood pressure reactivity in healthy black adolescents. Hypertension. 2000;35:496–500.PubMedCrossRef Wilson DK, Kliewer W, Pylobon L, Sica D. Socioeconomic status and blood pressure reactivity in healthy black adolescents. Hypertension. 2000;35:496–500.PubMedCrossRef
26.
Zurück zum Zitat Kokkinos P, Pittaras A, Narayan P, Faselis C, Singh S, Manolis A. Exercise capacity and blood pressure association with left ventricular mass in prehypertensive individuals. Hypertension. 2007;49(1):55–61.PubMedCrossRef Kokkinos P, Pittaras A, Narayan P, Faselis C, Singh S, Manolis A. Exercise capacity and blood pressure association with left ventricular mass in prehypertensive individuals. Hypertension. 2007;49(1):55–61.PubMedCrossRef
28.
Zurück zum Zitat Oyelola OO, Rufai MA. Plasma lipid, lipoprotein and apolipoprotein profiles in Nigerian university athletes and non-athletes. Br J Sports Med. 1993;27(4):271–4.PubMedCentralPubMedCrossRef Oyelola OO, Rufai MA. Plasma lipid, lipoprotein and apolipoprotein profiles in Nigerian university athletes and non-athletes. Br J Sports Med. 1993;27(4):271–4.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Nishijima H, Satake K, Igarashi K, Morita N, Kanazawa N, Okita K. Effects of exercise in overweight Japanese with multiple cardiovascular risk factors. Med Sci Sports Exerc. 2007;39:926–33.PubMedCrossRef Nishijima H, Satake K, Igarashi K, Morita N, Kanazawa N, Okita K. Effects of exercise in overweight Japanese with multiple cardiovascular risk factors. Med Sci Sports Exerc. 2007;39:926–33.PubMedCrossRef
30.
Zurück zum Zitat Okano G, Sato Y, Murata Y. Effect of mild walk habit on body composition, blood pressure and serum lipids. Jpn J Phys Fit Sport Med. 1990;39:315–23. Okano G, Sato Y, Murata Y. Effect of mild walk habit on body composition, blood pressure and serum lipids. Jpn J Phys Fit Sport Med. 1990;39:315–23.
31.
Zurück zum Zitat Vainionpaa A, Korpeleinen R, Kaikonen H, Knip M, Leppaluoto J, Jamsa T. Effect of impact exercise on physical performance and cardiovascular risk factors. Med Sci Sports Exerc. 2007;39(5):756–63.PubMedCrossRef Vainionpaa A, Korpeleinen R, Kaikonen H, Knip M, Leppaluoto J, Jamsa T. Effect of impact exercise on physical performance and cardiovascular risk factors. Med Sci Sports Exerc. 2007;39(5):756–63.PubMedCrossRef
32.
Zurück zum Zitat Marcovina SM, Gaur VP, Albers JJ. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apoliporoteins A-1 and B. Clin Chem. 1994;40(4):574–8.PubMed Marcovina SM, Gaur VP, Albers JJ. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apoliporoteins A-1 and B. Clin Chem. 1994;40(4):574–8.PubMed
33.
Zurück zum Zitat Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555–63.PubMedCrossRef Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555–63.PubMedCrossRef
Metadaten
Titel
A Randomized Controlled Trial of the Effects of Aerobic Dance Training on Blood Lipids Among Individuals with Hypertension on a Thiazide
verfasst von
Fatai A. Maruf
Aderonke O. Akinpelu
Babatunde L. Salako
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
High Blood Pressure & Cardiovascular Prevention / Ausgabe 4/2014
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-014-0063-2

Weitere Artikel der Ausgabe 4/2014

High Blood Pressure & Cardiovascular Prevention 4/2014 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.